edrophonium chloride

ed·ro·pho·ni·um chlor·ide

(ed'rō-fō'nē-ŭm klōr'id),
A rapid-acting, short-duration cholinesterase inhibitor used as an antidote for curariform drugs, as a diagnostic agent in myasthenia gravis, and in myasthenic crisis.

edrophonium chloride

[ed′rōfō′nē·əm]
a cholinesterase inhibitor that acts as an antidote to curare and other nondepolarizing neuromuscular blockers and is an aid in the diagnosis of myasthenia gravis.
indications It is prescribed to reverse neuromuscular blockade, to treat curare toxicity, and to aid in the diagnosis of suspected myasthenia gravis.
contraindications Obstruction of the GI or urinary tract, hypotension, bradycardia, or known hypersensitivity to this drug prohibits its use. Should be used with caution in patients with asthma and those taking cardiac glycosides.
adverse effects Among the most serious adverse effects are respiratory paralysis, hypotension, bradycardia, and bronchospasm.

ed·ro·pho·ni·um chlor·ide

(ed'rō-fō'nē-ŭm klōr'īd)
A rapid-acting, short-duration cholinesterase inhibitor used as an antidote for curariform drugs, as a diagnostic agent in myasthenia gravis, and in myasthenic crisis.
Mentioned in ?
References in periodicals archive ?
An edrophonium chloride test was interpreted as positive for myasthenia gravis, and intravenous immune globulin treatment was initiated.
Patient 1 also had a positive edrophonium chloride test, a finding indicative of myasthenia gravis and only rarely reported positive in botulism (3).
Botulism associated with home-fermented tofu in two Chinese immigrants--New York City, March-April 2012

Medical browser ?
Full browser ?